Diisopropylethylamine → 3-Bromo-N-((2S)-2-(4-fluorophenyl)-4-{3-[4-(morpholin-4-ylcarbonyl)piperidin-1-yl]azetidin-1-yl}butyl)-N-methyl-5-(trifluoromethyl)benzamide

HRID 426080Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 426080
[N:1]1([C:5]([CH:7]2[CH2:12][CH2:11][N:10]([CH:13]3[CH2:16][N:15]([CH2:17][CH2:18][C@@H:19]([C:36]4[CH:41]=[CH:40][C:39]([F:42])=[CH:38][CH:37]=4)[CH2:20][N:21]([CH3:35])[C:22](=[O:34])[C:23]4[CH:28]=[C:27]([C:29]([F:32])([F:31])[F:30])[CH:26]=[C:25]([Br:33])[CH:24]=4)[CH2:14]3)[CH2:9][CH2:8]2)=[O:6])[CH2:4][CH2:3][CH2:2]1.N1CC(N2CCC([C:53](N3CCOCC3)=[O:54])CC2)C1.CCN(C(C)C)C(C)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C(Cl)Cl.CO>[Br:33][C:25]1[CH:24]=[C:23]([CH:28]=[C:27]([C:29]([F:30])([F:32])[F:31])[CH:26]=1)[C:22]([N:21]([CH2:20][C@H:19]([C:36]1[CH:37]=[CH:38][C:39]([F:42])=[CH:40][CH:41]=1)[CH2:18][CH2:17][N:15]1[CH2:14][CH:13]([N:10]2[CH2:9][CH2:8][CH:7]([C:5]([N:1]3[CH2:4][CH2:3][O:54][CH2:53][CH2:2]3)=[O:6])[CH2:12][CH2:11]2)[CH2:16]1)[CH3:35])=[O:34]

Komponenten

7

Edukt 4

HCID 81531DiisopropylethylamineHCID 5049666Sodium triacetoxyborohydrideHCID 23582759N-[(2S)-4-{3-[4-(Azetidin-1-ylcarbonyl)piperidin-1-yl]azetidin-1-yl}-2-(4-fluorophenyl)butyl]-3-bromo-N-methyl-5-(trifluoromethyl)benzamideHCID 236589574-[(1-Azetidin-3-ylpiperidin-4-yl)carbonyl]morpholine

Produkt 1

HCID 236587773-Bromo-N-((2S)-2-(4-fluorophenyl)-4-{3-[4-(morpholin-4-ylcarbonyl)piperidin-1-yl]azetidin-1-yl}butyl)-N-methyl-5-(trifluoromethyl)benzamideAusbeute 53 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 887MethanolLösungsmittelHCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

3-Bromo-N-[(2S)-2-(4-fluorophenyl)-4-oxobutyl]-N-methyl-5-(trifluoromethyl)benzamide (see method 1; 0.14 g, 0.31 mmol) and 4-[(1-azetidin-3-ylpiperidin-4-yl)carbonyl]morpholine (see method 5; 0.11 g, 0.42 mmol) were dissolved in methylene chloride (10 mL) together dry methanol (0.2 mL). To the resultant solution were added DIPEA (0.12 g, 0.94 mmol) and sodium triacetoxyborohydride (0.13 g, 0.63 mmol). The mixture was stirred under nitrogen for 4 h at RT. The mixture was diluted with methylene chloride and washed twice with saturated aqueous NaHCO3 and then with brine. The organic phase was filtered through a phase separator and the solvent was removed by evaporation. The product was purified by chromatography on silica gel (methanol-methylene chloride, 10:1). There was obtained 0.11 g (53%) of the title compound as a white foam. 1H NMR (500 MHz, CDCl3): δ 1.4-3.8 (cm, 32H), 6.8-7.4 (cm, 6H), 7.7 (s, 1H); LCMS: m/z 684 (M+1)+.

Aufarbeitung

  1. washwashed twice with saturated aqueous NaHCO3
  2. filtrationThe organic phase was filtered through a phase separator
  3. customthe solvent was removed by evaporation
  4. customThe product was purified by chromatography on silica gel (methanol-methylene chloride, 10:1)

Quellen und Nachweise

ORD-Eintrag
ord-a518c5e7e82b44878e6031252a44bea4
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08106208B2

Notizen zur Reaktion

Wird geladen…